Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02891330
Other study ID # 2014_17
Secondary ID 2015-A00646-43
Status Completed
Phase N/A
First received
Last updated
Start date March 2, 2017
Est. completion date December 18, 2020

Study information

Verified date April 2021
Source University Hospital, Lille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The postprandial dumping syndrome is a frequent consequence of Roux-en-Y Gastric ByPass due to the rapid emptying of the stomach remnant in to the intestinal lumen. Dumping-related symptoms occur very early after eating (within 30 minutes), are not associated with concurrent hypoglycemia, and are most prominent in the early postoperative period. This syndrome very debilitating for the patient can be improved by dietary and nutritional recommendations. We hypothesize that a personalized approach based on dietary and nutritional recommendations conducted by a nurse would likely to decrease the frequency of dumping syndrome and improve the postoperative quality of life of patients in the early postoperative period.


Description:

The Roux-en-Y Gastric ByPass is considered the gold standard of weight loss surgery and is the most commonly performed bariatric procedure worldwide.The postprandial dumping syndrome is a frequent consequence of gastrojejunal anastomosis due to the rapid emptying of the stomach remnant in to the intestinal lumen. Dumping-related symptoms occur very early after eating (within 30 minutes), are not associated with concurrent hypoglycemia, and are most prominent in the early postoperative period. The symptoms of dumping syndrome include nausea, abdominal cramps, diarrhea, dizzy spells, weakness and cold sweats either with or after eating.This syndrome very debilitating for the patient can be improved by dietary and nutritional recommendations. We hypothesize that an individualized approach based on dietary and nutritional recommendations and monitoring of patients conducted by a nurse in the first three months after surgery would likely to decrease these problems and improve the postoperative quality of life of patients.


Recruitment information / eligibility

Status Completed
Enrollment 135
Est. completion date December 18, 2020
Est. primary completion date December 18, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Body Mass Index =40 kg / m2 or =35 kg / m2 in the presence of comorbidities related to obesity - Indication to Roux-en-Y Gastric ByPass Exclusion Criteria: - Contraindication to Roux-en-Y Gastric ByPass - Refusal to sign the consent form - Patient not affiliated to a social security system - Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Dietary and nutritional recommendations conducted by a nurse
Supplementary dietary and nutritional education

Locations

Country Name City State
France CH ARRAS Arras
France Ch Boulogne-Sur-Mer Boulogne Sur Mer
France Hôpital Claude Huriez, CHRU Lille
France Ch de Valenciennes Valenciennes

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The frequency of dumping syndrome The frequency of dumping syndrome at 3 months will be compared between the two groups. 3 months
Secondary Change in Body Mass Index 3 months
Secondary Frequence of Adverse Events after surgery at 1 and 3 months
Secondary Quality of Life-Lite questionnaire Estimation of quality of life by Impact of Weight on Quality of Life-Lite questionnaire(IWQOL-Lite) 3 months
Secondary Personal Effectiveness Assessment questionnaire (SEPOB) Measure the efficacy of therapeutic education by personal estimation of the level of skill using a specific obesity assessment questionnaire (SEPOB questionnaire or survey emotional, cognitive and behavioral sense of personal efficacy) 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05759689 - Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery N/A
Recruiting NCT04028193 - Fat Supplementation on Dumping Syndrome Associated Symptoms N/A
Recruiting NCT00543179 - Treatment of the Dumping Syndrome With Lanreotide Autogel® Phase 4
Not yet recruiting NCT04522193 - Dumping Syndrome and Esophageal Atresia N/A
Completed NCT02525705 - Dumping Syndrome After Operation of Esophageal Atresia Type III N/A
Completed NCT01794793 - Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Phase 4
Completed NCT03734627 - Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
Terminated NCT02836353 - Metabolic Consequences of Gastrointestinal Surgery N/A
Completed NCT05057819 - Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass Phase 4
Completed NCT02971631 - Gastrectomy, Eating Behaviour and GLP-1 N/A
Completed NCT01923649 - SOMATULINE Autogel 90 mg IN DUMPING SYNDROME Phase 2